(Q48003995)

English

The requirement of localized, CR2-mediated, alternative pathway activation of complement for covalent deposition of C3 fragments on normal B cells.

scientific article published in February 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9616366

The requirement of localized, CR2-mediated, alternative pathway activation of complement for covalent deposition of C3 fragments on normal B cells. (English)

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9616366

author name string

Olesen EH

1

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9616366

Johnson AA

2

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9616366

Damgaard G

3

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9616366

Leslie RG

4

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9616366

publication date

1 February 1998

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9616366

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9616366

93

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9616366

2

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9616366

177-183

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9616366

Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00429.X

21 January 2018

Malignant cells isolated from Burkitt's lymphoma but not other forms of leukemia activate the alternative complement pathway in human serum.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00429.X

21 January 2018

Complement-dependent cellular cytotoxicity: lymphoblastoid lines that activate complement component 3 (C3) and express C3 receptors have increased sensitivity to lymphocyte-mediated lysis in the presence of fresh human serum

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00429.X

21 January 2018

Evidence for three binding sites for C3 (hemolytically inactive), C3b and C3d on a CR2-positive Burkitt lymphoma-derived cell line (Raji).

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00429.X

21 January 2018

Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00429.X

21 January 2018

Quantitative measurement of Fc receptor activity on human peripheral blood monocytes and the monocyte-like cell line, U937, by laser flow cytometry

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00429.X

21 January 2018

An assay for the identification of antigens recognized by cytotoxic T cells, based on transient transfection of COS cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00429.X

21 January 2018

A comparative study of normal B cells and the EBV-positive Burkitt's lymphoma cell line, Raji, as activators of the complement system

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00429.X

21 January 2018

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00429.X

21 January 2018

The covalent-binding reaction of complement component C3

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00429.X

21 January 2018

Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00429.X

21 January 2018

Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00429.X

21 January 2018

CD21 is a ligand for CD23 and regulates IgE production

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00429.X

21 January 2018

In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00429.X

21 January 2018

Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00429.X

21 January 2018

C3d of complement as a molecular adjuvant: bridging innate and acquired immunity

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00429.X

21 January 2018

Alternative pathway of complement activation by human lymphoblastoid B and T cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/9616366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of the Immune Response by a Soluble Complement Receptor of B Lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9616366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of the alternative complement pathway by lymphoblastoid cell lines derived from patients with Burkitt's lymphoma and infectious mononucleosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9616366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CR2 is a complement activator and the covalent binding site for C3 during alternative pathway activation by Raji cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/9616366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2)

1 reference

https://pubmed.ncbi.nlm.nih.gov/9616366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polymeric C3dg primes human B lymphocytes for proliferation induced by anti-IgM.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9616366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Theoretical physics

1 reference

https://pubmed.ncbi.nlm.nih.gov/9616366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel mechanism of alternative pathway complement activation accounts for the deposition of C3 fragments on CR2-expressing homologous cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/9616366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complement alternative pathway activation by chronic lymphocytic leukemia cells: its role in their hepatosplenic localization

1 reference

https://pubmed.ncbi.nlm.nih.gov/9616366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CR2 is the primary acceptor site for C3 during alternative pathway activation of complement on human peripheral B lymphocytes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9616366

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1046/J.1365-2567.1998.00429.X

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9616366

0 references

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9616366

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48003995&oldid=1389961965"